News

Urgent warning over new ‘Ozempic’ side effect as scientists fear ‘tragic wave of people dying to lose weight’
BLOCKBUSTER ‘Ozempic-style’ fat jabs could increase the risk of depression and suicidal thoughts, experts have warned. The ...
Urgent caution over new ‘Ozempic’ side effect as scientists fear ‘tragic wave of people dying to lose weight’
BLOCKBUSTER ‘Ozempic-style’ fat jabs could increase the risk of depression and suicidal thoughts, experts have warned. The injections have allegedly helped celebs like Sun ...
Medscape4h
GLP-1 RAs in Eating Disorders: Promising or Perilous?
Experts express alarm that GLP-1 RAs may trigger or worsen eating disorders. But is there any role they might play in binge ...
Scientists call for 'urgent attention' after discovering harmful potential effects of Ozempic-like drugs
Blockbuster weight loss drugs like Ozempic could leave users at a higher risk of depression and suicidal thoughts, a ...
Medical Dialogues21h
New study reveals potential link between GLP1 agonists and depression: Calls for urgent attention
A groundbreaking study published in the journal Current Neuropharmacology highlights a concerning potential link between ...
Neurology Advisor23h
GLP-1 RAs, SGLT2 Inhibitors May Reduce Risk for Alzheimer Disease, Dementia in T2DM
Both GLP-1 RAs and SGLT2is are associated with a reduced risk for Alzheimer disease and related dementias among people with type 2 diabetes.
The Cardiology Advisor1d
2018 to 2022 Saw Increase in GLP-1 Receptor Agonist Use in Adults Without Diabetes
Among US adults without diabetes, the use of GLP-1 RAs increased from 2018 to 2022, reaching annual prevalence of 0.4% in 2022.
Weight loss at the cost of mental health? Study reveals Ozempic increases depression risk
A study shed light on the side effects of mental health, narrowing down those who are genetically more vulnerable.
GEN - Genetic Engineering and Biotechnology News2d
Region Specific Shifts in Dopamine Signaling Plays Role in Learning to Avoid Danger
Start listening today! The findings showed that dopamine signals in the two parts of the brain rise and fall in complex ...
Bristol Myers' Cobenfy fails in key study as add-on treatment for schizophrenia
Bristol Myers Squibb said on Tuesday its drug Cobenfy failed to show a statistically significant difference in a keenly ...
Think Twice Before Using Ozempic—New Study Links It To Mood Disorders And Brain Changes
A new study raises mental health concerns about popular weight loss drugs like Ozempic and Mounjaro. These GLP-1 agonists, while effective for appetite control, may disrupt dopamine pathways linked to ...